** = Publications listed in SCI/SSCI/Pubmed
** Hodl, I; Sallegger, C; Forstner, P; Sareban, N; Moritz, M; Dreo, B; Schulz, E; Lackner, A; Kleinhappl, B; Hatzl, S; Moazedi-Fürst, F; Seifert-Held, T; Heschl, B; Khalil, M; Enzinger, C; Greinix, H; Stradner, MH; Steinmetz, I; Schlenke, P; Fessler, J
Altered cellular immune response to vaccination against SARS-CoV-2 in patients suffering from autoimmunity with B-cell depleting therapy.
Microbes Infect. 2023; 25(4):105103
Doi: 10.1016/j.micinf.2023.105103
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Sourij, C; Aziz, F; Kojzar, H; Obermayer, AM; Sternad, C; Müller, A; Tripolt, NJ; Pferschy, PN; Aberer, F; Schlenke, P; Kleinhappl, B; Stradner, M; Sareban, N; Moritz, M; Dominguez-Villar, M; Oliver, N; Steinmetz, I; Sourij, H
Severe acute respiratory syndrome coronavirus 2 spike antibody level decline is more pronounced after the second vaccination, but response to the third vaccination is similar in people with type 1 and type 2 diabetes compared with healthy controls: The prospective COVAC-DM cohort study.
Diabetes Obes Metab. 2023; 25(1): 314-318.
Doi: 10.1111/dom.14855
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Sourij, C; Aziz, F; Kojzar, H; Obermayer, A; Sternad, C; Forstner, P; Muller, A; Tripolt, N; Pferschy, P; Aberer, F; Schlenke, P; Kleinhappl, B; Stradner, M; Sareban, N; Moritz, M; Dominguez-Villar, M; Oliver, N; Sourij, H
SARS-CoV-2S antibody formation is not impaired in people with type 1 or type 2 diabetes, but the antibody level falls more rapidly in this collective - the -COVAC-DM study
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 4):259-260.
[Oral Communication]
Web of Science
** Schulz, E; Hodl, I; Forstner, P; Hatzl, S; Sareban, N; Moritz, M; Fessler, J; Dreo, B; Uhl, B; Url, C; Grisold, AJ; Khalil, M; Kleinhappl, B; Enzinger, C; Stradner, MH; Greinix, HT; Schlenke, P; Steinmetz, I
CD19+IgD+CD27- Naïve B Cells as Predictors of Humoral Response to COVID 19 mRNA Vaccination in Immunocompromised Patients.
Front Immunol. 2021; 12:803742
Doi: 10.3389/fimmu.2021.803742
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Drexler, C; Macher, S; Lindenau, I; Holter, M; Moritz, M; Stojakovic, T; Pieber, TR; Schlenke, P; Amrein, K
High-dose intravenous versus oral iron in blood donors with iron deficiency: The IronWoMan randomized, controlled clinical trial.
Clin Nutr. 2020; 39(3):737-745
Doi: 10.1016/j.clnu.2019.03.025
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Macher, S; Herster, C; Holter, M; Moritz, M; Matzhold, EM; Stojakovic, T; Pieber, TR; Schlenke, P; Drexler, C; Amrein, K
The Effect of Parenteral or Oral Iron Supplementation on Fatigue, Sleep, Quality of Life and Restless Legs Syndrome in Iron-Deficient Blood Donors: A Secondary Analysis of the IronWoMan RCT.
Nutrients. 2020; 12(5):
Doi: 10.3390/nu12051313
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG